LBF20306HX02: Difference between revisions
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism=Trioxilin B3 is produced by hydrolysis of hepoxilin B3 with ammonium sulfate fraction of rat lung cytosol [[Reference:Pace-Asciak_CR:Reynaud_D:Demin_PM:,Lipids,1995,30,107|{{RelationTable/GetFirstAuthor|Reference:Pace-Asciak_CR:Reynaud_D:Demin_PM:,Lipids,1995,30,107}}]]. | |Metabolism=Trioxilin B3 is produced by hydrolysis of hepoxilin B3 with ammonium sulfate fraction of rat lung cytosol [[Reference:Pace-Asciak_CR:Reynaud_D:Demin_PM:,Lipids,1995,30,107|{{RelationTable/GetFirstAuthor|Reference:Pace-Asciak_CR:Reynaud_D:Demin_PM:,Lipids,1995,30,107}}]]. | ||
|Symbol=TrXB3 | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 21:00, 6 January 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR5111 |
| LipidMaps | LMFA03090004 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20306HX02 |
| TRIOXILIN B3 | |
|---|---|
| |
| Structural Information | |
| 10,11 (S) ,12 (R) -Trihydroxyeicosa-5,8,14 (Z,Z,Z) -trienoic acid | |
| |
| TrXB3 | |
| Formula | C20H34O5 |
| Exact Mass | 354.240624198 |
| Average Mass | 354.48096000000004 |
| SMILES | [C@@H](O)([C@@H](C(O)C=CCC=CCCCC(O)=O)O)CC=CCCCCC |
| Physicochemical Information | |
| Trioxilin B3 is produced by hydrolysis of hepoxilin B3 with ammonium sulfate fraction of rat lung cytosol Pace-Asciak_CR et al.. | |
| Spectral Information | |
| Mass Spectra | METHYL ESTER TRIS-TMS ETHER ; m/e 342, 315, 269, 225, 213, 129(base peak) Pace-Asciak_CR et al. |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
